Prevalence of Hypoparathyroidism in Australia
It is estimated that hypoparathyroidism affects approximately 1 in 2,000 people in the general population worldwide. However, there is limited data on the prevalence of hypoparathyroidism specifically in Australia. The condition is considered to be rare, but it can occur at any age and affects both men and women equally.
Due to the rarity of the condition, it can be challenging for patients to find appropriate care and support. It is important for healthcare providers to be aware of the symptoms of hypoparathyroidism and to provide appropriate diagnosis and treatment to improve the quality of life for patients living with the condition.
As there is limited data on the prevalence of hypoparathyroidism specifically in Australia, it can be challenging for patients to find appropriate care and support. This is where CaSR Patient Support can help.
CaSR Patient Support is an ACNC Registered Health Promotion Charity that aims to promote awareness, provide knowledge and support, and improve health outcomes for patients of chronic endocrine disorders involving calcium regulation, including hypoparathyroidism. The organization provides a range of services to support patients and their families, including information resources, access to support groups, and advocacy for patients’ rights.
Through its support programs, CaSR Patient Support can help patients with hypoparathyroidism to connect with others who understand their condition, access information about the latest research and treatments, and receive guidance on managing their symptoms. This can help to improve the quality of life for patients living with hypoparathyroidism.
Additionally, CaSR Patient Support works to raise awareness of hypoparathyroidism among healthcare providers and the wider community, to ensure that patients receive timely and appropriate diagnosis and treatment. By advocating for patients’ rights and promoting research into new treatments for hypoparathyroidism, CaSR Patient Support is making a valuable contribution to the fight against this rare but challenging condition.
